Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD

Neurobiology of Aging

Volumn 27, Issue 11, 2006, Pages 1564-1576

  Sultana, Rukhsana ^a,b   Boyd Kimball, Debra ^a,b   Poon, H Fai ^a,b   Cai, Jian ^c   Pierce, William M ^c   Klein, Jon B ^d   Merchant, Michael ^d   Markesbery, William R ^a,b   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

SNAP; Alzheimer's disease; Carbonic anhydrase II; Cerebellum; Dihydropyrimidinase related protein 2; Enolase; Hippocampus; Peptidyl prolyl cis trans isomerase; Phosphoglycerate mutase 1; Protein oxidation; Redox proteomics; Triose phosphate isomerase; Ubiquitin c terminal hydroxylase 1

Indexed keywords

ALPHA ENOLASE; BINDING PROTEIN; CARBONATE DEHYDRATASE II; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CYCLOPHILIN; GAMMA SOLUBLE NSF ATTACHMENT PROTEIN; PHOSPHOGLYCERATE MUTASE; TRIOSEPHOSPHATE ISOMERASE; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOMICS; SENILE PLAQUE; SYNAPTIC MEMBRANE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; CEREBELLUM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HIPPOCAMPUS; HUMANS; HYDRAZINES; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MATCHED-PAIR ANALYSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; PROTEOMICS; TRYPSIN;

EID: 33748423353     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.09.021     Document Type: Article

References (90)

1. Aksenova M.V., Aksenov M.Y., Payne R.M., Trojanowski J.Q., Schmidt M.L., Carney J.M., et al. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders. Dement Geriatr Cogn Disord 10 2 (1999) 158-165
2. Andersson B., Nyman P.O., and Strid L. Amino acid sequence of human erythrocyte carbonic anhydrase B. Biochem Biophys Res Commun 48 3 (1972) 670-677
3. Ball M.J., Fisman M., Hachinski V., Blume W., Fox A., Kral V.A., et al. A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1 8419 (1985) 14-16
4. Beckers C.J., Block M.R., Glick B.S., Rothman J.E., and Balch W.E. Vesicular transport between the endoplasmic reticulum and the Golgi stack requires the NEM-sensitive fusion protein. Nature 339 6223 (1989) 397-398
5. Boyd-Kimball D., Castegna A., Sultana R., Poon H.F., Petroze R., Lynn B.C., et al. Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Res 1044 2 (2005) 206-215
6. Boyd-Kimball D., Poon H.F., Lynn B., Cai J., Pierce W.M., Klein J., et al. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): implications for Alzheimer's disease. Neurobiol Aging 27 9 (2006) 1239-1249
7. Boyd-Kimball D., Sultana R., Fai Poon H., Lynn B.C., Casamenti F., Pepeu G., et al. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience 132 2 (2005) 313-324
8. Boyd-Kimball D., Sultana R., Poon H.F., Mohmmad-Abdul H., Lynn B.C., Klein J.B., et al. Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach. J Neurosci Res 79 5 (2005) 707-713
9. Butterfield D.A. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 1000 1/2 (2004) 1-7
10. Butterfield D.A., and Boyd-Kimball D. Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration. Int Rev Neurobiol 61 (2004) 159-188
11. Butterfield D.A., Boyd-Kimball D., and Castegna A. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J Neurochem 86 6 (2003) 1313-1327
12. Butterfield D.A., Castegna A., Lauderback C.M., and Drake J. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23 5 (2002) 655-664
13. Butterfield D.A., and Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32 11 (2002) 1050-1060
14. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33 4 (2002) 562-571
15. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82 6 (2002) 1524-1532
16. Castegna A., Thongboonkerd V., Klein J., Lynn B.C., Wang Y.L., Osaka H., et al. Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins. J Neurochem 88 6 (2004) 1540-1546
17. Castegna A., Thongboonkerd V., Klein J.B., Lynn B., Markesbery W.R., and Butterfield D.A. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85 6 (2003) 1394-1401
18. Castellani R.J., Harris P.L., Lecroisey A., Izadi-Pruneyre N., Wandersman C., Perry G., et al. Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease. Antioxid Redox Signal 2 1 (2000) 137-142
19. Choi J., Levey A.I., Weintraub S.T., Rees H.D., Gearing M., Chin L.S., et al. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279 13 (2004) 13256-13264
20. Clary D.O., Griff I.C., and Rothman J.E. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast. Cell 61 4 (1990) 709-721
21. Coleman P.D., and Flood D.G. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 8 (1987) 521-545
22. Conrad C.C., Talent J.M., Malakowsky C.A., and Gracy R.W. Post-electrophoretic identification of oxidized proteins. Biol Proced Online 2 (2000) 39-45
23. Dalle-Donne I, Scaloni A, Butterfield DA. Redox proteomics. New York: Wiley, in press.
24. Dang L.C., Melandri F.D., and Stein R.L. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 37 7 (1998) 1868-1879
25. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27 5 (1990) 457-464
26. Del Villar K., and Miller C.A. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA 101 12 (2004) 4210-4215
27. Desai C., Garriga G., McIntire S.L., and HH R. A genetic pathway for the development of the Caenorhabditis elegans HSN motor neurons. Nature 336 (1988) 638-646
28. Devasahayam G., Chaturvedi V., and Hanes S.D. The Ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans. Genetics 160 1 (2002) 37-48
29. Fernley R.T. Non-cytoplasmic carbonic anhydrases. Trends Biochem Sci 13 9 (1988) 356-359
30. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83 13 (1986) 4913-4917
31. Harris R.C., Essen B., and Hultman E. Glycogen phosphorylase activity in biopsy samples and single muscle fibres of musculus quadriceps femoris of man at rest. Scand J Clin Lab Invest 36 6 (1976) 521-526
32. Hedgecock E.M., Culotti J.G., Thomson J.N., and PL A. Axonal guidance mutants of Caenorhabditis elegans identified by filling sensory neurons with fluorescein dyes. Dev Biol 111 (1985) 158-170
33. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65 5 (1995) 2146-2156
34. Holzer M., Gartner U., Stobe A., Hartig W., Gruschka H., Bruckner M.K., et al. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol (Berl) 104 5 (2002) 471-481
35. Iwangoff P., Armbruster R., Enz A., and Meier-Ruge W. Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech Ageing Dev 14 1/2 (1980) 203-209
36. Katzman R., and Saitoh T. Advances in Alzheimer's disease. FASEB J 5 3 (1991) 278-286
37. Keller J.N., Hanni K.B., and Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J Neurochem 75 1 (2000) 436-439
38. Kurt M.A., Davies D.C., Kidd M., Duff K., and Howlett D.R. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Neurobiol Dis 14 1 (2003) 89-97
39. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78 2 (2001) 413-416
40. Lauderback C.M., Hackett J.M., Keller J.N., Varadarajan S., Szweda L., Kindy M., et al. Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease. Biochemistry 40 8 (2001) 2548-2554
41. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233 (1994) 346-357
42. Lovell M.A., Xie C., and Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22 2 (2001) 187-194
43. Lu K.P., Hanes S.D., and Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380 6574 (1996) 544-547
44. Lu P.J., Wulf G., Zhou X.Z., Davies P., and Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399 6738 (1999) 784-788
45. Lubec G., Nonaka M., Krapfenbauer K., Gratzer M., Cairns N., and Fountoulakis M. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. J Neural Transm Suppl 57 (1999) 161-177
46. 2 elimination. Annu Rev Physiol 50 (1988) 695-717
47. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., and Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem 68 1 (1997) 255-264
48. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23 1 (1997) 134-147
49. Markesbery W.R., and Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol 9 1 (1999) 133-146
50. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19 1 (1998) 33-36
51. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10 2 (1995) 509-519
52. Masliah E., Mallory M., Hansen L., Alford M., Albright T., DeTeresa R., et al. Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6 5 (1991) 729-739
53. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., and Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174 1 (1994) 67-72
54. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
55. Meier-Ruge W., Iwangoff P., and Reichlmeier K. Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch Gerontol Geriatr 3 2 (1984) 161-165
56. Messier C., and Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 75 1-2 (1996) 1-11
57. Mohmmad-Abdul H., and Butterfield D. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease. Biochim Biophys Acta 1741 1-2 (2004) 140-148
58. Morgan A., Dimaline R., and Burgoyne R.D. The ATPase activity of N-ethylmaleimide-sensitive fusion protein (NSF) is regulated by soluble NSF attachment proteins. J Biol Chem 269 47 (1994) 29347-29350
59. Ogawa M., Fukuyama H., Ouchi Y., Yamauchi H., and Kimura J. Altered energy metabolism in Alzheimer's disease. J Neurol Sci 139 1 (1996) 78-82
60. Perluigi M., Fai Poon H., Hensley K., Pierce W.M., Klein J.B., Calabrese V., et al. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 38 7 (2005) 960-968
61. Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, et al. Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice-a model of Huntington's disease. Mol Cell Proteomics, in press.
62. Perry R.T., Collins J.S., Wiener H., Acton R., and Go R.C. The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging 22 6 (2001) 873-883
63. Planel E., Miyasaka T., Launey T., Chui D.H., Tanemura K., Sato S., et al. Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 24 10 (2004) 2401-2411
64. Poon H.F., Castegna A., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., et al. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126 4 (2004) 915-926
65. Poon H.F., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., Morley J.E., et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 46 2 (2005) 159-168
66. Poon H.F., Frasier M., Shreve N., Calabrese V., Wolozin B., and Butterfield D.A. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice-a model of familial Parkinson's disease. Neurobiol Dis 18 3 (2005) 492-498
67. Poon H.F., Hensley K., Thongboonkerd V., Merchant M.L., Lynn B., Pierce W.M., et al. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 39 4 (2005) 453-462
68. Ramakrishnan P., Dickson D.W., and Davies P. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol Dis 14 2 (2003) 251-264
69. Scheff S.W., and Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24 8 (2003) 1029-1046
70. Schonberger S.J., Edgar P.F., Kydd R., Faull R.L., and Cooper G.J. Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics 1 12 (2001) 1519-1528
71. Schutkowski M., Bernhardt A., Zhou X.Z., Shen M., Reimer U., Rahfeld J.U., et al. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry 37 16 (1998) 5566-5575
72. Shen M., Stukenberg P.T., Kirschner M.W., and Lu K.P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 12 5 (1998) 706-720
73. Shringarpure R., Grune T., and Davies K.J. Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells. Cell Mol Life Sci 58 10 (2001) 1442-1450
74. Sly W.S., Hewett-Emmett D., Whyte M.P., Yu Y.S., and Tashian R.E. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80 9 (1983) 2752-2756
75. Sly W.S., and Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64 (1995) 375-401
76. Sly W.S., Whyte M.P., Sundaram V., Tashian R.E., Hewett-Emmett D., Guibaud P., et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 313 3 (1985) 139-145
77. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17 8 (1997) 2653-2657
78. Smith M.A., Richey P.L., Taneda S., Kutty R.K., Sayre L.M., Monnier V.M., et al. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci 738 (1994) 447-454
79. Stadtman E.R., and Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 10 5 (1997) 485-494
80. Stenbeck G. Soluble NSF-attachment proteins. Int J Biochem Cell Biol 30 5 (1998) 573-577
81. Su J.H., Anderson A.J., Cribbs D.H., Tu C., Tong L., Kesslack P., et al. Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis 12 3 (2003) 182-193
82. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., et al. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol Aging 27 7 (2006) 918-925
83. Sultana R., and Butterfield D.A. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products. Neurochem Res 29 12 (2004) 2215-2220
84. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30 4 (1991) 572-580
85. Thongboonkerd V., Luengpailin J., Cao J., Pierce W.M., Cai J., Klein J.B., et al. Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors. J Biol Chem 277 19 (2002) 16599-16605
86. Wagner S., Breiteneder H., Simon-Nobbe B., Susani M., Krebitz M., Niggemann B., et al. Hev b 9, an enolase and a new cross-reactive allergen from hevea latex and molds. Purification, characterization, cloning and expression. Eur J Biochem 267 24 (2000) 7006-7014
87. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 1 (2004) 181-193
88. Whiteheart S.W., Griff I.C., Brunner M., Clary D.O., Mayer T., Buhrow S.A., et al. SNAP family of NSF attachment proteins includes a brain-specific isoform. Nature 362 6418 (1993) 353-355
89. Wilson D.W., Whiteheart S.W., Wiedmann M., Brunner M., and Rothman J.E. A multisubunit particle implicated in membrane fusion. J Cell Biol 117 3 (1992) 531-538
90. Zhao M., Cribbs D.H., Anderson A.J., Cummings B.J., Su J.H., Wasserman A.J., et al. The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain. Neurochem Res 28 2 (2003) 307-318